Page last updated: 2024-08-24

valsartan and Overweight

valsartan has been researched along with Overweight in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bianco, C; Caccamo, M; Fang, W; Kido, K; Sokos, G	1
Corradi, L; Derosa, G; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Santoro, T; Zoppi, A	1
Abraham, I; Brié, H; Cholette, M; Ciesielski, G; Hermans, C; Kinsey, K; Lee, C; MacDonald, K; Pacheco, C; Reel, S; Song, M; Speaks, P; Van der Niepen, P; Vancayzeele, S; Yee, B	1

Trials

1 trial(s) available for valsartan and Overweight

Article	Year
Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patients. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:21 Topics: Adult; Aged; Amlodipine; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Hypertension; Insulin; Male; Middle Aged; Obesity; Overweight; Prospective Studies; Tetrazoles; Valine; Valsartan	2008

Other Studies

2 other study(ies) available for valsartan and Overweight

Article	Year
Association of Body Mass Index With Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan. Journal of cardiovascular pharmacology and therapeutics, 2021, Volume: 26, Issue:6 Topics: Aged; Aged, 80 and over; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Body Mass Index; Cause of Death; Cohort Studies; Drug Combinations; Heart Failure; Humans; Male; Middle Aged; Overweight; Retrospective Studies; Risk Factors; Stroke Volume; Valsartan; West Virginia	2021
Patient- and physician-level determinants of blood pressure response to treatment in normal weight and overweight patients (the PREVIEW study). Nutrition, metabolism, and cardiovascular diseases : NMCD, 2013, Volume: 23, Issue:4 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Belgium; Blood Pressure; Body Mass Index; Body Weight; Clinical Competence; Female; Guideline Adherence; Humans; Hypertension; Linear Models; Logistic Models; Male; Medication Adherence; Middle Aged; Odds Ratio; Overweight; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prospective Studies; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan	2013

Article

Year

Association of Body Mass Index With Clinical Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan.

Journal of cardiovascular pharmacology and therapeutics, 2021, Volume: 26, Issue:6

Topics: Aged; Aged, 80 and over; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Body Mass Index; Cause of Death; Cohort Studies; Drug Combinations; Heart Failure; Humans; Male; Middle Aged; Overweight; Retrospective Studies; Risk Factors; Stroke Volume; Valsartan; West Virginia

2021

Patient- and physician-level determinants of blood pressure response to treatment in normal weight and overweight patients (the PREVIEW study).

Nutrition, metabolism, and cardiovascular diseases : NMCD, 2013, Volume: 23, Issue:4

Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Belgium; Blood Pressure; Body Mass Index; Body Weight; Clinical Competence; Female; Guideline Adherence; Humans; Hypertension; Linear Models; Logistic Models; Male; Medication Adherence; Middle Aged; Odds Ratio; Overweight; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prospective Studies; Risk Factors; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan

2013